The results of the study demonstrated that IOX1 suppresses P-glycoproteins (P-gp) in cancer cells via the JMJD1A/-catenin/P-gp pathway and synergistically increases DOX-induced immune-stimulatory immunogenic cell death. The gene discussed is PGP; the disease is cancer.